NEW YORK (GenomeWeb) – Accelerate Diagnostics faces a class action lawsuit from shareholders alleging that the firm intentionally misled investors about the capabilities of its rapid diagnostic platform.

The class action suit was filed in the US District Court for the District of Arizona by plaintiff Brian Rapp on behalf of all persons or entities that purchased Accelerate Diagnostics securities between March 7, 2014 and Feb. 17, 2015. The suit names the firm, President and CEO Lawrence Mehren, and CFO Steve Reichling as defendants.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.